PPI Healthcare Consulting
PPi Healthcare Consulting Ltd is a global leader in pharmaceutical pricing, reimbursement, and market access consultancy. With an international network of country-based experts, the company provides tailored strategies and insights to facilitate successful market entry, growth, and access for pharmaceutical, medical device, and biotech sectors. Established with over 20 years of experience per expert, PPi HC has a proven track record of over 2600 country assignments since 2002, offering comprehensive support from early investment decisions to post-launch lifecycle management. Their expertise spans across therapeutic areas and healthcare industries, emphasizing local knowledge integrated into a cohesive global strategy.
Industries
Nr. of Employees
small (1-50)
PPI Healthcare Consulting
Products
Market Access Consulting Services
Comprehensive market access support throughout development and commercialisation processes, from early investment decisions to launch planning and post-launch lifecycle price modulation.
Pharmaceutical Pricing and Reimbursement Consulting
Consulting services providing expert guidance on pharmaceutical pricing, reimbursement, and market access strategy across international healthcare systems.
Payer & Stakeholder research and insights
Comprehensive market research and stakeholder insight services to frame market access strategies and support specialty pharmaceuticals and innovative devices.
Landscape Assessments
Landscape assessments provided by PPi Healthcare Consulting as an early component of clinical and commercial planning to understand market features, dynamics, patient referral pathways, HTA regulations, and stakeholder identification.
Value and Access Strategy
Consulting services providing guidance on clinical programmes, reimbursement needs, market access, and distribution issues for novel healthcare technologies.
P&R Due Diligence Assessment for 2 agents
Assessment of the prospective pricing and reimbursement environment for 2 novel formulation drugs to support a client's decision whether to in-licence the products.
Market Access Consulting Services
Comprehensive market access support throughout development and commercialisation processes, from early investment decisions to launch planning and post-launch lifecycle price modulation.
Pharmaceutical Pricing and Reimbursement Consulting
Consulting services providing expert guidance on pharmaceutical pricing, reimbursement, and market access strategy across international healthcare systems.
Payer & Stakeholder research and insights
Comprehensive market research and stakeholder insight services to frame market access strategies and support specialty pharmaceuticals and innovative devices.
Landscape Assessments
Landscape assessments provided by PPi Healthcare Consulting as an early component of clinical and commercial planning to understand market features, dynamics, patient referral pathways, HTA regulations, and stakeholder identification.
Value and Access Strategy
Consulting services providing guidance on clinical programmes, reimbursement needs, market access, and distribution issues for novel healthcare technologies.
P&R Due Diligence Assessment for 2 agents
Assessment of the prospective pricing and reimbursement environment for 2 novel formulation drugs to support a client's decision whether to in-licence the products.
Services
Cross-country analyses of therapeutic landscapes, competitors, care pathways and market access barriers to inform strategic decisions.
Design of integrated market access plans covering evidence needs, payer positioning and reimbursement pathways across target jurisdictions.
Primary research with payers and stakeholders to capture perceptions of unmet need, comparator positioning and reimbursement decision drivers.
Development of pricing approaches considering market dynamics, reference pricing and commercial objectives.
Design of country-specific reimbursement dossiers and stakeholder approaches to secure coverage and favourable terms.
Preparation and support for HTA dossier submissions and associated country-specific evidence packages.
Cross-country analyses of therapeutic landscapes, competitors, care pathways and market access barriers to inform strategic decisions.
Design of integrated market access plans covering evidence needs, payer positioning and reimbursement pathways across target jurisdictions.
Primary research with payers and stakeholders to capture perceptions of unmet need, comparator positioning and reimbursement decision drivers.
Development of pricing approaches considering market dynamics, reference pricing and commercial objectives.
Design of country-specific reimbursement dossiers and stakeholder approaches to secure coverage and favourable terms.
Preparation and support for HTA dossier submissions and associated country-specific evidence packages.
Expertise Areas
- Market access and reimbursement strategy
- Pricing strategy and international pricing analysis
- Health economics and pharmacoeconomic modelling
- Health Technology Assessment (HTA) submission support
Key Technologies
- Health Technology Assessment (HTA) methodologies
- Pharmacoeconomic modelling
- Budget-impact analysis
- Payer and stakeholder qualitative/quantitative research methods
News & Updates
Adam Barak presented on engaging with pharma from a pricing and reimbursement perspective for rare diseases, discussing challenges, funding, and pricing considerations.
Adam Barak presented on engaging with pharma from a pricing and reimbursement perspective for rare diseases, discussing challenges, funding, and pricing considerations.